• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗癌药物使肿瘤细胞对肿瘤坏死因子相关凋亡诱导配体介导的半胱天冬酶-8激活和凋亡敏感。

Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.

作者信息

Lacour S, Hammann A, Wotawa A, Corcos L, Solary E, Dimanche-Boitrel M T

机构信息

Institut National de la Santé et de la Recherche Médicale U517, Facultés de Médicine et de Pharmacie, Dijon, France.

出版信息

Cancer Res. 2001 Feb 15;61(4):1645-51.

PMID:11245478
Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a new cytokine that was proposed to specifically induce apoptosis of cancer cells. In tumor cells that are resistant to the cytokine, subtoxic concentrations of chemotherapeutic drugs can restore the response to TRAIL. The present study further explores the mechanisms that determine tumor cell sensitivity to TRAIL by comparing four human colon carcinoma cell lines We show that colon cancer cell sensitivity to TRAIL-induced apoptosis and cytotoxicity correlates with the expression of the death receptors TRAIL-R1 and TRAIL-R2 at the cell surface, as determined by now cytometry, whereas the two decoy receptors TRAIL-R3 and TRAIL-R4 can be detected only in permeabilized cells. Clinically relevant concentrations of cisplatin and doxorubicin sensitize the most resistant colon cancer cell lines to TRAIL-induced cell death without modifying the expression nor the localization of TRAIL receptors in these cells. TRAIL induces the activation of procaspase-8 and triggers caspase-dependent apoptosis off colon cancer cells. Cytotoxic drugs lower the signaling threshold required for TRAIL-induced procaspase-8 activation. In turn, caspase-8 cleaves Bid, a BH3 domain-containing proapoptotic molecule of the Bcl-2 family and activates effector caspases. Together, these data indicate that chemotherapeutic drugs sensitize colon tumor cells to TRAIL-mediated caspase-8 activation and apoptosis.

摘要

肿瘤坏死因子相关凋亡诱导配体(TRAIL)是一种新的细胞因子,被认为可特异性诱导癌细胞凋亡。在对该细胞因子耐药的肿瘤细胞中,亚毒性浓度的化疗药物可恢复对TRAIL的反应。本研究通过比较四种人结肠癌细胞系,进一步探讨了决定肿瘤细胞对TRAIL敏感性的机制。我们发现,通过流式细胞术测定,结肠癌细胞对TRAIL诱导的凋亡和细胞毒性的敏感性与细胞表面死亡受体TRAIL-R1和TRAIL-R2的表达相关,而两种诱饵受体TRAIL-R3和TRAIL-R4仅在通透化细胞中可检测到。临床相关浓度的顺铂和阿霉素可使最耐药的结肠癌细胞系对TRAIL诱导的细胞死亡敏感,而不改变这些细胞中TRAIL受体的表达和定位。TRAIL诱导procaspase-8的激活,并触发结肠癌细胞的caspase依赖性凋亡。细胞毒性药物降低了TRAIL诱导procaspase-8激活所需的信号阈值。反过来,caspase-8切割Bid,Bid是Bcl-2家族中一个含BH3结构域的促凋亡分子,并激活效应caspase。总之,这些数据表明化疗药物使结肠肿瘤细胞对TRAIL介导的caspase-8激活和凋亡敏感。

相似文献

1
Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.抗癌药物使肿瘤细胞对肿瘤坏死因子相关凋亡诱导配体介导的半胱天冬酶-8激活和凋亡敏感。
Cancer Res. 2001 Feb 15;61(4):1645-51.
2
Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.化疗药物使肉瘤细胞系对肿瘤坏死因子相关凋亡诱导配体诱导的半胱天冬酶-8激活、凋亡及线粒体膜电位丧失敏感。
J Orthop Res. 2003 Sep;21(5):949-57. doi: 10.1016/S0736-0266(03)00062-7.
3
Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells.化疗增强HT29人结肠癌细胞中肿瘤坏死因子相关凋亡诱导配体死亡诱导信号复合体的组装。
Oncogene. 2003 Mar 27;22(12):1807-16. doi: 10.1038/sj.onc.1206127.
4
Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.化疗药物与肿瘤坏死因子相关凋亡诱导配体/Apo-2配体在体内对乳腺癌细胞凋亡及肿瘤消退的协同相互作用。
Cancer Res. 2003 Sep 1;63(17):5390-400.
5
Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.TRAIL与化疗联合应用对化疗耐药卵巢癌细胞凋亡的协同诱导作用
Gynecol Oncol. 2001 Jun;81(3):380-90. doi: 10.1006/gyno.2001.6194.
6
Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.活性氧调节肿瘤坏死因子相关凋亡诱导配体耐药的人结肠癌细胞系中的半胱天冬酶激活。
Cancer Res. 2005 Aug 15;65(16):7436-45. doi: 10.1158/0008-5472.CAN-04-2628.
7
Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.通过长时间暴露于肿瘤坏死因子相关凋亡诱导配体而选择出的对凋亡具有抗性的人黑色素瘤细胞,对顺铂诱导的坏死性细胞死亡更敏感。
Clin Cancer Res. 2006 Feb 15;12(4):1355-64. doi: 10.1158/1078-0432.CCR-05-2084.
8
Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.尤因肉瘤家族性肿瘤对肿瘤坏死因子相关凋亡诱导配体敏感,并表达死亡受体4和死亡受体5。
Cancer Res. 2001 Mar 15;61(6):2704-12.
9
Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.通过抑制酪蛋白激酶II使肿瘤细胞对Apo2配体/TRAIL诱导的凋亡致敏。
Cancer Res. 2002 Aug 1;62(15):4180-5.
10
Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis.阿霉素使耐阿霉素的8226/Dox40人多发性骨髓瘤细胞对Apo2L/肿瘤坏死因子相关凋亡诱导配体介导的(TRAIL)凋亡敏感。
Clin Cancer Res. 2001 Dec;7(12):3874-83.

引用本文的文献

1
Chemo-Immunotherapy: A New Trend in Cancer Treatment.化学免疫疗法:癌症治疗的新趋势。
Cancers (Basel). 2023 May 25;15(11):2912. doi: 10.3390/cancers15112912.
2
Apoptosis-related gene expression can predict the response of ovarian cancer cell lines to treatment with recombinant human TRAIL alone or combined with cisplatin.凋亡相关基因表达可预测卵巢癌细胞系对重组人 TRAIL 单独或联合顺铂治疗的反应。
Clinics (Sao Paulo). 2020;75:e1492. doi: 10.6061/clinics/2020/e1492. Epub 2020 Mar 13.
3
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis.
三氧化二砷增强自然杀伤细胞对急性早幼粒细胞白血病的细胞毒性,同时抑制其生物发生。
Front Immunol. 2018 Jun 14;9:1357. doi: 10.3389/fimmu.2018.01357. eCollection 2018.
4
Synergistic effect of TRAIL and irradiation in elimination of glioblastoma stem-like cells.TRAIL 与放疗协同消除脑胶质瘤干细胞。
Clin Exp Med. 2018 Aug;18(3):399-411. doi: 10.1007/s10238-018-0504-7. Epub 2018 May 18.
5
Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells.二甲双胍通过Mule介导的Mcl-1降解增强TRAIL诱导的结肠癌细胞凋亡。
Oncotarget. 2016 Sep 13;7(37):59503-59518. doi: 10.18632/oncotarget.11147.
6
Targeting death receptors: is this trail still hot?靶向死亡受体:这条研究路径仍然热门吗?
Transl Pediatr. 2013 Apr;2(2):66-9. doi: 10.3978/j.issn.2224-4336.2013.02.01.
7
The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer.益生菌费氏丙酸杆菌作为基于TRAIL的结直肠癌治疗新佐剂
Oncotarget. 2016 Feb 9;7(6):7161-78. doi: 10.18632/oncotarget.6881.
8
Serial low doses of sorafenib enhance therapeutic efficacy of adoptive T cell therapy in a murine model by improving tumor microenvironment.连续低剂量索拉非尼通过改善肿瘤微环境增强了过继性T细胞疗法在小鼠模型中的治疗效果。
PLoS One. 2014 Oct 15;9(10):e109992. doi: 10.1371/journal.pone.0109992. eCollection 2014.
9
Effect of TRAIL in combination with DDP on the expression of MDR1 gene in gastric cancer cells.TRAIL联合顺铂对胃癌细胞中MDR1基因表达的影响。
Prz Gastroenterol. 2014;9(4):214-9. doi: 10.5114/pg.2014.45103. Epub 2014 Sep 16.
10
Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells.Bcl-xL/Beclin-1在分泌型TRAIL武装腺病毒联合丝裂霉素C及热疗对结肠癌细胞的协同凋亡作用中的作用
Apoptosis. 2014 Nov;19(11):1603-15. doi: 10.1007/s10495-014-1028-6.